IR@PKUHSC  > 北京大学第三临床医学院  > 肿瘤放疗科
学科主题临床医学
Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation as Salvage Therapy for Recurrent Head and Neck Carcimonas
Jiang, Ping1; Jiang, Yuliang1; Wang, Jun-Jie1; Meng, Na1; Ran, Weiqiang2; Qu, Ang1; Yang, Ruijie1
关键词head and neck (125)I seed implantation outcome recurrent carcinoma ultrasonography
刊名CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2011-12-01
DOI10.1089/cbr.2010.0844
26期:6页:753-757
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Medicine, Research & Experimental ; Pharmacology & Pharmacy ; Radiology, Nuclear Medicine & Medical Imaging
资助者Foundation of Capital Medical Development and Research ; Foundation of Capital Medical Development and Research
研究领域[WOS]Oncology ; Research & Experimental Medicine ; Pharmacology & Pharmacy ; Radiology, Nuclear Medicine & Medical Imaging
关键词[WOS]RADIATION-THERAPY ; SEED IMPLANTATION ; EUROPEAN-ORGANIZATION ; I125 IMPLANTS ; CANCER ; CARCINOMA ; REIRRADIATION ; BRACHYTHERAPY ; RADIOTHERAPY ; ADJUVANT
英文摘要

Twenty-nine (29) patients with recurrent head and neck carcinomas underwent (125)I seed permanent implantation under ultrasonography guidance and the feasibility and efficacy of (125)I seed implantation were assessed. The postplan evaluation showed that the actuarial D90 of (125)I seeds ranged from 90 to 160 Gy (median, 130 Gy). The activity of each (125)I seed ranged from 0.35 to 0.8 mCi (median, 0.6 mCi). The total number of sources implanted ranged from 3 to 61 (median, 22). The follow-up ranged from 3 to 40 months (median, 8 months). The 1-, 2-, and 3-year local control rates were 53.1%, 34.8%, and 17.4%, respectively, with a median local control of 16 months (95% confidence interval, 5.8-26.1). The 1-, 2-, and 3-year survival rates were 54.1%, 27.5%, and 27.5%, respectively (median, 13 months; 95% confidence interval, 6.0-19.9). Of the 25 patients, 5 (17.2%) died of local recurrence and 7 (24.1%) died of metastases; 2 patients showed recurrences at 3 and 8 months after seed implantation and subsequently died of pneumonia. One (1) patient died of heart disease. One (1) developed ulceration with tumor progression. Blood vessel damage and neuropathy were not observed. Percutaneous ultrasound-guided (125)I seed implantation is a feasible, safe salvage for patients with recurrent carcinomas of the head and neck.

语种英语
所属项目编号2009-2024
资助者Foundation of Capital Medical Development and Research ; Foundation of Capital Medical Development and Research
WOS记录号WOS:000298144600009
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66011
专题北京大学第三临床医学院_肿瘤放疗科
作者单位1.Peking Univ, Dept Radiat Oncol, Hosp 3, Beijing 100191, Peoples R China
2.Peking Univ, Dept Ultrasound, Hosp 3, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Jiang, Ping,Jiang, Yuliang,Wang, Jun-Jie,et al. Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation as Salvage Therapy for Recurrent Head and Neck Carcimonas[J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS,2011,26(6):753-757.
APA Jiang, Ping.,Jiang, Yuliang.,Wang, Jun-Jie.,Meng, Na.,Ran, Weiqiang.,...&Yang, Ruijie.(2011).Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation as Salvage Therapy for Recurrent Head and Neck Carcimonas.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS,26(6),753-757.
MLA Jiang, Ping,et al."Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation as Salvage Therapy for Recurrent Head and Neck Carcimonas".CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 26.6(2011):753-757.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Jiang, Ping]的文章
[Jiang, Yuliang]的文章
[Wang, Jun-Jie]的文章
百度学术
百度学术中相似的文章
[Jiang, Ping]的文章
[Jiang, Yuliang]的文章
[Wang, Jun-Jie]的文章
必应学术
必应学术中相似的文章
[Jiang, Ping]的文章
[Jiang, Yuliang]的文章
[Wang, Jun-Jie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。